Profiel
Mr. Graham Parry is a Research Analyst at Merrill Lynch International.
He is a Managing Director and head of Healthcare equity research.
Based in London, he heads up the European healthcare equity research team with direct coverage responsibility for European large cap pharmaceuticals and biotechnology.
He has headed European pharmaceuticals research since 2004, where he has successfully built out the team to become consistently highly rated in its sector in the Institutional Investor survey.
Mr. Parry initially joined Merrill Lynch in 2003 as Global pharmaceuticals/healthcare specialist sales, joining from ABN Amro where he was a pharmaceutical and biotechnology equity research analyst.
He started his career in equity sales in 1997 at JB Were and Son, now part of Goldman Sachs.
He studied at Oxford University where he gained a master’s degree in Biochemistry.
Actieve functies van Graham Parry
| Bedrijven | Functie | Begin |
|---|---|---|
Merrill Lynch International
 Merrill Lynch International Investment Banks/BrokersFinance Merrill Lynch International (MLI-UK) is a brokerage firm headquartered in London, UK. The firm was founded in 1988 and is a subsidiary of ML UK Capital Holdings Ltd., ultimately owned by Bank of America Corp. (NYSE: BAC) in the US. MLI-UK provides brokerage services to individual and retail clients. | Analyst-Equity | 01-01-2004 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
Merrill Lynch International
Merrill Lynch International Investment Banks/BrokersFinance Merrill Lynch International (MLI-UK) is a brokerage firm headquartered in London, UK. The firm was founded in 1988 and is a subsidiary of ML UK Capital Holdings Ltd., ultimately owned by Bank of America Corp. (NYSE: BAC) in the US. MLI-UK provides brokerage services to individual and retail clients. | Finance |
